FINAL EXAM NR566 REAL EXAM QUESTIONS AND DETAILED SOLUTIONS 2026 COMPLETE REVIEW

FINAL EXAM NR566 REAL EXAM QUESTIONS
AND DETAILED SOLUTIONS 2026 COMPLETE
REVIEW

◉ 1st generation cephalosporins susceptible pathogens. Answer:
gram positive staphylococci and streptococci


◉ 2nd-5th generations cephalosporins susceptible pathogens.
Answer: broad spectrum gram positive and gram negative bacteri


◉ 1st generation cephalosporins clinical use. Answer: strep
pharyngitis
skin infections
surgical prophylaxis


◉ 2nd generation cephalosporin clinical use. Answer: otitis
sinusitis
resp tract infections


◉ 3rd generation cephalosporin clinical use. Answer: meningitis

, ◉ 4th generation cephalosporin clinical use. Answer: hospital
acquired pneumonia
complicated intra-abdominal and urinary tract infections


◉ 5th generation cephalosporin clinical use. Answer: MRSA
infections


◉ all cephalosporins can promote______ instruct patient to report
increase in ____________. Answer: CDIFF
Stool frequency


◉ which generation cephalosporins are used to treat bacterial
infections in neonates and infants. Answer: 3rd


◉ are cephalosporins safe for use in children/adolescents. Answer:
yes, commonly used to treat bacterial infections in children


◉ which drug has a black box warning for use in pregnancy
secondary to risk for adverse developmental outcome. Answer:
Televancin


◉ are cephalosporins safe in pregnancy. Answer: yes


◉ are cephalosporins safe for breastfeeding. Answer: yes